FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type: (check all that apply) 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type: (check all that apply) 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

  
gfedcb

If this a report of a second or subsequent transplant, check here and continue with 100-day follow-up insert.

 
 
1  What was the date of diagnosis of Osteopetrosis? __ __ __ __ - __ __- __ __  

 
 

2  Specify the inheritance of osteopetrosis:

    
 nmlkji

autosomal recessive  

 nmlkji
autosomal recessive with carbanhydrase II deficiency  

 nmlkji
autosomal dominant  

 nmlkji
Unknown  

 

Specify the presence of the following clinical indicators of osteopetrosis: 
 

3  aplastic anemia

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

4  blindness / visual impairment

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

5  convulsions

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

6  dentition problems

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

7  exophthalmos

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

8  fractures

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

  Key Fields 

Osteopetrosis Pre-HSCT Data Questions: 1 - 2

  Clinical and Radiological Findings Prior to the Preparative Regimen Questions: 3 - 34

Form 2036 R2.0: Osteopetrosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2036 revision 2.0 last updated July 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 5



 
 

9  frontal bossing / prominent forehead

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

10  gross motor delay

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

11  hearing impairment

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

12  height below 5th percentile

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

13  hepatomegaly

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

14  hypertelorism

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

15  mental development delay

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

16  nasal congestion

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

17  osteomyelitis

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

18  septicemia

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

19  skull circumference above 95th percentile

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

20  splenomegaly

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

21  strabismus / nystagmus

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

22  other hematologic impairment(s)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
23  Specify hematologic impairment:    

 
 

24  other clinical finding

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
25  specify other finding    

 

Specify the presense of the following radiologic indicators of osteopetrosis: 
 

26  "Batman sign" / "sign du masque"

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

27  bone-in-bone

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

28  cerebral atrophy (by MRI or CT)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

Form 2036 R2.0: Osteopetrosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2036 revision 2.0 last updated July 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 5



 
 

29  craniosynostosis

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

30  hydrocephalus

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

31  increased general skeletal sclerosis

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

32  metaphyseal widening

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

33  other radiologic finding

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
34  specify other finding:    

 
 

35  Was calcitrol given to treat osteopetrosis at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

36  What was the time duration calcitrol was given?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
37  .    months 

 
 

38  What was the date administration of calcitrol was stopped?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
39  . __ __ __ __ - __ __- __ __  

 
 

40  Were corticosteroids given to treat osteopetrosis at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

41  What was the time duration corticosteriods were given?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
42  .    months 

 
 

43  What was the date administration of corticosteroids was stopped?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
44  . __ __ __ __ - __ __- __ __  

 
 

45  Was IFN-γ given to treat osteopetrosis at any time prior to the preperative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

46  What was the time duration IFN-γ was given?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
47  .    months 

 
 

48  What was the date administration of IFN-? was stopped?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
49  . __ __ __ __ - __ __- __ __  

 
 

50  Was any other drug given to treat osteopetrosis at any time prior to preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
51  Specify other drug:    

  Disease Treatment Given Prior to the Preparative Regimen Questions: 35 - 62

Form 2036 R2.0: Osteopetrosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2036 revision 2.0 last updated July 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 5



 
 

52  What was the time duration the drug was given?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
53  .    months 

 
 

54  What was the date administration of the drug was stopped?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
55  . __ __ __ __ - __ __- __ __  

 
 

56  Did the recipient undergo any red blood transfusions at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

57  Specify the number of donor exposures (best estimate):

    
 nmlkji

1-5  
 nmlkji

6-10  
 nmlkji

11-20  
 nmlkji

>20  
 nmlkji

Unknown  

 
 

58  Did the recipient undergo any platelet transfusions at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

59  Specify the number of donor exposures (best estimate):

    
 nmlkji

1-5  
 nmlkji

6-10  
 nmlkji

11-20  
 nmlkji

>20  
 nmlkji

Unknown  

 
 

60  Did the recipient undergo a bone marrow biopsy at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

  
 
61  Specify the date the bone marrow biopsy was performed: __ __ __ __ - __ __- __ __  

 
  

gfedcb
Date unknown

 
 

62  Specify the bone marrow biopsy results

    
 nmlkji

Normal  
 nmlkji

Abnormal  
 nmlkji

Unknown  

 
 

63  Absolute lymphocyte count (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
64  .    

 
Unit:

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

65  Absolute neutrophil count (ANC) (untransfused)

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
66  .    

 
Unit:

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

67  Absolute monocyte count (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
68  .    

 
Unit:

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

69  Reticulocytes (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
70  .    % 

  Hematologic Findings Immediately Prior to the Preparative Regimen Questions: 63 - 72

Form 2036 R2.0: Osteopetrosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2036 revision 2.0 last updated July 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 5



 
 

71  Was a bone biopsy performed within 2 weeks prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

72  Specify number of osteoclasts in bone biopsy:

    
 nmlkji

few / none  
 nmlkji

Normal  
 nmlkji

Increased  
 nmlkji

Unknown  

  
 
First Name:    

 
Last Name:    

  
 
Phone:    

 
Fax:    

 
 
E-mail address:    

Form 2036 R2.0: Osteopetrosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2036 revision 2.0 last updated July 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 5 / 5